6265-57-2Relevant academic research and scientific papers
Room temperature HFIP/Ag-promoted palladium-catalyzed C–H functionalization of benzothiazole with iodoarenes
Bhujbal, Yuvraj,Gharpure, Santosh J.,Kapdi, Anant R.,Kommyreddy, Saidurga Prasad,Kori, Santosh,Vadagaonkar, Kamlesh
supporting information, p. 847 - 850 (2022/02/01)
A versatile synthetic protocol involving the room temperature direct arylation of benzothiazole with a wide variety of iodoarenes under Ag-promoted Pd-catalyzed conditions in HFIP as the reaction solvent has been presented. A sequential HFIP-promoted sele
4-Acetamidobenzaldehyde derivatives as biological active candidates; synthesis, anti-oxidant, anti-alzheimer and DNA binding studies
Murtaza, Shahzad,Tatheer, Adina
, p. 957 - 968 (2018/08/17)
Background: Due to high demand of developing new compounds to solve the health issues, paracetamol resembling 4-acetamidobenzaldehyde was derivatized into different new compounds including important pharmacophores (benzimidazole, benzothiazole). The synth
Novel green procedure for the synthesis of 2-arylbenzothiazoles under microwave irradiation in Peg 200 or Peg 400
Deligeorgiev, Todor G.,Kaloyanova, Stefka,Vasilev, Aleksey,Vaquero, Juan J.
experimental part, p. 2292 - 2302 (2011/01/12)
An improved green procedure for the synthesis of 2-aryl- and 2-hetarylbenzothiazoles by condensation of equivalent amounts of 2,2'-diaminodiphenyldisulfides or 2-aminothiophenols and various aromatic aldehydes in PEG 200/400 under microwave irradiation has been developed. This method allows the synthesis of 2-arylbenzothiazoles in high yields and with high purity regardless of the state of the starting compounds (liquid or solid) or the nature of the substituents in the aromatic ring. Copyright Taylor & Francis Group, LLC.
2-arylbenzazole compounds
-
, (2008/06/13)
There are disclosed herein 2-phenylbenzazole compounds having a 3'-substituent and a 4'-NR2R6 substituent in the phenyl group where R5 and R6 are each hydrogen or alkyl, or where the $'-NR5R6 substituent is N-acyl (or N-benzoyl). There are also disclosed
Antitumor benzothiazoles. 8.1 Synthesis, metabolic formation, and biological properties of the C- and N-oxidation products of antitumor 2-(4- aminophenyl)-benzothiazoles
Kashiyama, Eiji,Hutchinson, Ian,Chua, Mei-Sze,Stinson, Sherman F.,Phillips, Lawrence R.,Kaur, Gurmeet,Sausville, Edward A.,Bradshaw, Tracey D.,Westwell, Andrew D.,Stevens, Malcolm F. G.
, p. 4172 - 4184 (2007/10/03)
2-(4-Aminophenyl)benzothiazoles 1 and their N-acetylated forms have been converted to C and N-hydroxylated derivatives to investigate the role of metabolic oxidation in the mode of action of this series of compounds. 2-(4- Amino-3-methylphenyl)benzothiazole (1a, DF 203, NSC 674495) is a novel and potent antitumor agent with selective growth inhibitory properties against human cancer cell lines. Very low IC50 values (14C]1a derived radioactivity was observed in the sensitive MCF-7 cell line but not in the insensitive MDA-MB-435 cell line. The mechanism of growth inhibition by 1a, which is unknown, may be dependent on the differential metabolism of the drug to an activated form by sensitive cell lines only and its covalent binding to an intracellular protein. However, the 6-hydroxy derivative 6c is not the 'active' metabolite since, like all other C- and N-hydroxylated benzothiazoles examined in this study, it is devoid of antitumor properties in vitro.
Antitumor benzothiazoles. 7. Synthesis of 2-(4- acylaminophenyl)benzothiazoles and investigations into the role of acetylation in the antitumor activities of the parent amines
Chua, Mei-Sze,Shi, Dong-Fang,Wrigley, Samantha,Bradshaw, Tracey D.,Hutchinson, Ian,Shaw, P. Nicholas,Barrett, David A.,Stanley, Lesley A.,Stevens, Malcolm F. G.
, p. 381 - 392 (2007/10/03)
2-(4-Aminophenyl)benzothiazoles display potent and selective antitumor activity against inter alia breast, ovarian, colon, and renal cell lines, but their mechanism of action, though yet to be defined, may be novel. Metabolism is suspected to play a central role in the mode of action of these benzothiazoles since drug uptake and biotransformation were observed in sensitive cell lines (e.g., breast MCF-7 and MDA 468 cells) in vitro, whereas insensitive cell lines (e.g., prostate PC 3 cells) showed negligible uptake and biotransformation. N-Acyl derivatives of the arylamines have been synthesized, and in vitro studies confirm N-acetylation and oxidation as the main metabolic transformations of 2-(4-aminophenyl)benzothiazoles. With the predominant process being dictated by the nature of the 3'-substituent. The prototype amine 3 underwent mainly N-acetylation in vitro, while 3'- substituted analogues 4 and 5 were primarily oxidized. N-Acetylation of 4 to 11 exerts a drastic dyschemotherapeutic effect in vitro, but acetylation of the halogeno congeners 5-7 gave acetylamines 12-14 which substantially retain selective antitumor activity. In vivo pharmacokinetic studies in rats confirmed rapid and exclusive N-acetylation of the 3'-methyl analogue 4, but less acetylation with the 3'-chloro analogue 5. Distinct expression patterns of N-acetyltransferase NAT1 and NAT2 have been demonstrated in our panel of cell lines.
